Welcome to our dedicated page for Corvel SEC filings (Ticker: CRVL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how CorVel Corporation converts advanced analytics into lower claim costs is vital, yet the company’s SEC paperwork is a maze of healthcare billing codes, captive insurance structures, and network contracting jargon. If you have ever searched “What does CorVel report in its 10-K?” or tried to locate a single footnote on network revenue in a 300-page filing, you know the challenge. Stock Titan resolves that frustration by layering AI-driven language models on top of every disclosure, turning raw documents into plain-English takeaways you can scan in seconds.
Open the CorVel annual report 10-K simplified to see segment profitability, risk factors, and how the CareMC platform scales. Need the latest CorVel quarterly earnings report 10-Q filing? We post it within minutes of hitting EDGAR and attach side-by-side KPI trends. Material updates, such as new managed-care contracts or Medicare set-aside rulings, appear under CorVel 8-K material events explained. Our dashboard also streams CorVel insider trading Form 4 transactions and CorVel executive stock transactions Form 4 so you can watch ownership shifts in real time and cross-check details in the CorVel proxy statement executive compensation section.
Whether you’re benchmarking medical cost containment peers or simply want CorVel SEC filings explained simply, Stock Titan’s tools help you:
- Spot margin shifts with CorVel earnings report filing analysis.
- Receive CorVel Form 4 insider transactions real-time on any device.
- Compare claim volume trends across regions without reading every exhibit.
- Understand complex reimbursement tables with AI-powered summaries.
All filings update automatically, and every paragraph links back to the source so analysts, insurers, and portfolio managers can trust the detail while saving hours. Understanding CorVel SEC documents with AI no longer requires a legal background—just open the page and let the insights surface.
Jennifer Yoss, Vice President of Accounting at CorVel Corp (CRVL), reported a purchase of 35 shares of CorVel common stock on 09/30/2025 at a price of $73.549 per share. The shares were acquired under the issuer's Employee Stock Purchase Plan in a transaction exempt under SEC Rule 16b-3(c). Following the purchase, Ms. Yoss beneficially owns 2,123 shares, held directly. The Form 4 was signed on behalf of the reporting person by Sharon O'Connor on 10/01/2025.
Michael G. Combs, CEO & President of CorVel Corp (CRVL), reported a purchase of 44 shares of the issuer's common stock on 09/30/2025 at a per-share price of $73.549. The acquisition was made under the company's Employee Stock Purchase Plan and is noted as exempt under SEC Rule 16b-3(c). After the transaction, Mr. Combs beneficially owned 44,325 shares. The Form 4 was submitted as a single-person filing and signed on behalf of the reporting person on 10/01/2025.
Mark E. Bertels, Executive Vice President - Risk Management Services at CorVel Corp (CRVL), reported an open-market acquisition under the companys Employee Stock Purchase Plan on 09/30/2025. The filing shows 8 shares acquired at a price of $73.549 per share, bringing his direct beneficial ownership to 2,594 shares. The purchase is described as exempt under SEC Rule 16b-3(c). The Form 4 was signed on behalf of Mr. Bertels by Sharon O'Connor on 10/01/2025.
CorVel Corporation insider filing reports a proposed Rule 144 sale of 18,000 common shares through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $1,580,823.00. The filer states those shares were acquired by stock option exercise on 09/11/2025 and paid for in cash the same day. The filing also discloses that the same person sold 12,000 shares on 08/20/2025 for gross proceeds of $1,069,975.20. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
CorVel Corp (CRVL) Form 4 filing: Corstar Holdings Inc. reported a sale of 70,000 shares of CorVel common stock on 09/08/2025 at a price of $91.46 per share, leaving 18,742,108 shares beneficially owned following the transaction. The filing indicates the sale was made under a Rule 10b5-1 trading plan adopted May 28, 2025. The Form 4 is signed on behalf of the reporting entity and lists the reporting person as a director and 10% owner. The transaction is recorded as a direct disposition of common stock and no derivative transactions are reported.
Brandon O'Brien, identified as Chief Financial Officer of CorVel Corp (CRVL), reported a sale of company stock on 09/08/2025. The Form 4 shows 1,764 shares were sold at a price of $91.5367 per share, leaving 8,948 shares beneficially owned following the transaction. The filing was submitted on behalf of Mr. O'Brien by Sharon O'Connor on 09/10/2025. The disposition is reported as a direct holding.
Corvel Corp (CRVL) Form 4: Corstar Holdings, Inc., filed by Jeffrey Michael as reporting person, reported a sale of 40,000 shares of Corvel common stock on 09/02/2025 at a reported price of $88.848 per share. After the sale, the reporting person beneficially owned 18,812,108 shares. The filing indicates the reporter is a director and the Form 4 was filed by one reporting person.
Form 144 notice discloses a proposed sale of 70,000 shares of common stock through UBS Financial Services on 09/08/2025 with an aggregate market value of $6,402,200.00. The filing reports 51,312,748 shares outstanding for the class. The shares were acquired as founders' shares on 05/01/1991. The filer also reported a sale within the past three months of 40,000 common shares on 09/02/2025 for gross proceeds of $3,553,923.00. The form includes the standard seller representation that no material nonpublic information is known to the seller.
CorVel Corporation insider filing discloses a proposed sale of 1,764 common shares through Morgan Stanley Smith Barney LLC on 09/08/2025, with an aggregate market value of $161,470.74. The filing reports the company's outstanding common shares as 51,312,748, placing the proposed sale at a very small fraction of total shares.
The securities were acquired by exercise of options: 591 shares on 08/01/2024 and 1,173 shares on 01/02/2024, both paid in cash. The filer, identified as Brandon T O'Brien, also sold 3,957 shares on 06/09/2025 for $429,162.77. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
CorVel Corp (CRVL) Form 144 notice: A holder intends to sell 40,000 shares of common stock through UBS Financial Services on the NASDAQ, with an aggregate market value reported as $3,555,773.00 and an approximate sale date of 09/02/2025. The shares were acquired as Founders Shares from the issuer on 05/01/1991 and the filer reports no securities sold in the past three months. The notice includes the standard representation that the seller does not possess undisclosed material adverse information. The filing provides broker details and basic transaction disclosure but no forward guidance, financial results, or additional context about the holder.
FAQ
What is the current stock price of Corvel (CRVL)?
What is the market cap of Corvel (CRVL)?
